![Gary Acton](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Gary Acton worked as a Managing Director for the European Region at CTI BioPharma Corp.
He was a Non-Executive Director at Neuropharm Group Plc from 2007 to 2010.
He also worked as a Vice President for Clinical Development at Ligand UK Ltd. and as a Chief Medical Officer at Sarossa Capital Ltd.
Former positions of Gary Acton
| Companies | Position | End |
|---|---|---|
Neuropharm Group Plc
 Neuropharm Group Plc Pharmaceuticals: MajorHealth Technology Develops and manufactures speciality pharmaceuticals | Director/Board Member | 11/07/2010 |
| CTI BIOPHARMA CORP. | Corporate Officer/Principal | - |
| VERNALIS | Chief Tech/Sci/R&D Officer | - |
Sarossa Capital Ltd.
 Sarossa Capital Ltd. Financial ConglomeratesFinance Provides investment services | Chief Tech/Sci/R&D Officer | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
5
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
CTI BioPharma Corp.
 CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology Engages in acquisition, development and commercialization of novel targeted therapies for blood-related cancers | Health Technology |
Ligand UK Ltd.
 Ligand UK Ltd. BiotechnologyHealth Technology Engages in research and development & sells pharmaceutical products | Health Technology |
Neuropharm Group Plc
Neuropharm Group Plc Pharmaceuticals: MajorHealth Technology Develops and manufactures speciality pharmaceuticals | Health Technology |
Sarossa Capital Ltd.
Sarossa Capital Ltd. Financial ConglomeratesFinance Provides investment services | Finance |
- Stock Market
- Insiders
- Gary Acton
